Qube Research & Technologies (QRT)
VERV

Qube Research & Technologies (QRT)’s Verve Therapeutics VERV Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio VERV Stock Details VERV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-33,115
Closed -$440K – 4769
2024
Q1 		$440K Buy
+33,115
New +$439K ﹤0.01% 2604
2023
Q3 		– Sell
-10,224
Closed -$192K – 4345
2023
Q2 		$192K Sell
10,224
-25,219
-71% -$420K ﹤0.01% 1793
2023
Q1 		$511K Buy
+35,443
New +$694K ﹤0.01% 1560
2022
Q2 		– Sell
-12,155
Closed -$277K – 3169
2022
Q1 		$277K Buy
+12,155
New +$347K ﹤0.01% 1829
2021
Q3 		– Sell
-12,730
Closed -$767K – 2804
2021
Q2 		$767K Buy
+12,730
New +$528K 0.01% 1052

Other funds holding VERV

AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return

Qube Research & Technologies (QRT)'s VERV Position: Q2 2024 in Review

Qube Research & Technologies (QRT) sold out of Verve Therapeutics (VERV) in Q2 2024, closing a stake of 33,115 shares — an estimated $440K sold.

Qube Research & Technologies (QRT) first reported a position in VERV in Q2 2021 and held it in 5 quarters. The position peaked at $767K in Q2 2021. 166 funds tracked by Wall St. Rank hold VERV as of Q2 2024.

  • Qube Research & Technologies (QRT) reported no remaining Verve Therapeutics position as of Q2 2024 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 33,115 Verve Therapeutics shares in Q2 2024, an estimated $440K.
  • Qube Research & Technologies (QRT) first reported a position in Verve Therapeutics in Q2 2021 and held it in 5 quarters.
  • Qube Research & Technologies (QRT)'s Verve Therapeutics position peaked at $767K in Q2 2021.
  • 166 funds tracked by Wall St. Rank held Verve Therapeutics as of Q2 2024.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2024, filed 14 Aug 2024.